Extracellular matrix organization

Extracellular matrix organization" is not the name of a molecule or receptor, but rather refers to the highly regulated biological process by which the components of the extracellular matrix (ECM) are assembled, modified, and spatially arranged within tissues. This process involves the production, secretion, and organization of structural proteins (such as collagen, elastin, fibronectin, and laminin), proteoglycans, and glycoproteins, and is mediated by various enzymes, molecular chaperones, and interactions with cell-surface receptors like integrins. Organized ECM is essential for tissue structure, mechanical strength, cell signaling, migration, and repair after injury. Aberrant or dysregulated ECM organization is implicated in the pathology of fibrosis, tumor progression, and other diseases. Because "extracellular matrix organization" is a complex multi-protein process rather than a discrete molecular entity, it does not have properties like a canonical abbreviation or direct interacting drugs as a single target[1][2][3][4][5][7]. Key Points: - "Extracellular matrix organization" is a *biological process*, not a molecule, receptor, or canonical drug target. - The process is crucial for tissue integrity, repair, and remodeling, and its dysregulation is linked to numerous diseases[1][2][4][5][7]. - Targeting ECM organization therapeutically generally involves modulating the activity of ECM-remodeling enzymes (such as matrix metalloproteinases), individual ECM proteins, or their cell surface receptors, not the "organization" process as a single molecular entity. Conclusion: "Extracellular matrix organization" is not a valid, specific molecular target, but rather a collective biological function/process, so it cannot be directly mapped to the requested structured target fields.

Other names

ECM organizationorganization of extracellular matrixextracellular matrix remodeling